Department of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Ann Nucl Med. 2019 Sep;33(9):657-670. doi: 10.1007/s12149-019-01380-7. Epub 2019 Jun 19.
To investigate the role of the traditional and radiomic parameters of F-FDG PET for predicting the outcomes of patients with esophageal squamous cell carcinoma (SqCC).
Forty-four patients with primary esophageal SqCC who underwent neoadjuvant chemoradiotherapy (CCRT) followed by esophagectomy (tri-modality treatment) were retrospectively analyzed. All patients underwent F-FDG PET/CT before and after neoadjuvant CCRT. The radiomic features were calculated using the pre-treatment PET scan. Pre-treatment radiomic features and changes in the PET-derived traditional parameters after neoadjuvant CCRT were analyzed according to the pathological response to esophagectomy, disease-free survival (DFS), and overall survival (OS). We further developed a scoring system based on the independent survival prognosticators and compared our model to the traditional TNM staging system and surgical pathology.
A pre-treatment primary tumor histogram entropy ≥ 3.69 predicts an unfavorable response to neoadjuvant CCRT (OR = 19.25, p = 0.009). An SUVmax reduction ratio ≤ 0.76, a pre-treatment primary tumor code similarity ≤ 0.0235, and incomplete pathological remission were independently associated with poor OS (p = 0.019, 0.033, and 0.038, respectively) and DFS (p = 0.049, 0.021, and 0.009, respectively). The three survival prognosticators were used to construct a scoring system (score 0-1, 2, and 3). Patients with a score of 2 or 3 had a significantly worse survival outcome than those with a score of 0-1 (HRs for OS: 3.58 for score 2, and 15.19 for score 3, p < 0.001; HRs for DFS: 1.39 for score 2 and 6.04 for score 3, p = 0.001).This survival prediction model was superior to the traditional TNM staging system (p < 0.001 versus p = 0.061 for OS, and p = 0.001 versus p = 0.027 for DFS) and the model based on surgical pathology (p < 0.001 versus p = 0.049 for OS, and p = 0.001 versus p = 0.022 for DFS).
The F-FDG PET-derived radiomic parameter is useful for predicting the surgical pathological response in patients with esophageal SqCC treated with the tri-modality method. Using a combination of traditional and radiomic PET parameters with clinical profiles enables better stratification of patients into subgroups with various survival rates.
探讨正电子发射断层扫描(PET)的传统参数和放射组学参数在预测食管鳞状细胞癌(SqCC)患者结局中的作用。
回顾性分析 44 例接受新辅助放化疗(CCRT)后行食管切除术(三联治疗)的原发性食管 SqCC 患者。所有患者在新辅助 CCRT 前后均接受 F-FDG PET/CT 检查。使用预处理 PET 扫描计算放射组学特征。根据手术病理的病理反应、无病生存率(DFS)和总生存率(OS),分析新辅助 CCRT 后预处理时的放射组学特征和 PET 衍生的传统参数的变化。我们进一步基于独立的生存预后因素建立了一个评分系统,并将我们的模型与传统的 TNM 分期系统和手术病理进行了比较。
预处理原发性肿瘤直方图熵值≥3.69 预测新辅助 CCRT 反应不良(OR=19.25,p=0.009)。SUVmax 降低率≤0.76、预处理原发性肿瘤代码相似性≤0.0235 和不完全病理缓解与较差的 OS(p=0.019、0.033 和 0.038)和 DFS(p=0.049、0.021 和 0.009)独立相关。这三个生存预后因素被用来构建一个评分系统(评分 0-1、2 和 3)。评分 2 或 3 的患者的生存结果明显比评分 0-1 的患者差(OS 的 HRs:评分 2 为 3.58,评分 3 为 15.19,p<0.001;DFS 的 HRs:评分 2 为 1.39,评分 3 为 6.04,p=0.001)。这种生存预测模型优于传统的 TNM 分期系统(p<0.001 与 p=0.061 比较 OS,p=0.001 与 p=0.027 比较 DFS)和基于手术病理的模型(p<0.001 与 p=0.049 比较 OS,p=0.001 与 p=0.022 比较 DFS)。
F-FDG PET 衍生的放射组学参数可用于预测三联治疗的食管 SqCC 患者的手术病理反应。使用传统和放射组学 PET 参数与临床特征相结合,可以更好地将患者分为不同生存率的亚组。